Issue 733 of Veto: Decision 480 and Drug Price Review
The article concerns the semi-annual review of drug pricing, where prices are evaluated every six months in a manner similar to fuel market studies. Expectations are for new increases in medication prices during the first quarter of 2027. According to the report, drug prices are expected to experience additional hikes as a result of these ongoing reviews, which will impact markets and consumers.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)